Functions and biosynthesis of plasmalogens in health and disease.

Plasmalogens (1-O-alk-1'-enyl-2-acyl glycerophospholipids) constitute a special class of phospholipids characterized by the presence of a vinyl-ether bond at the sn-1 position. Although long considered as biological peculiarities, interest in this group of phospholipids has grown in recent years, thanks to the realization that plasmalogens are involved in different human diseases. In this review, we summarize the current state of knowledge with respect to the enzymatic synthesis of plasmalogens, the characteristic topology of the enzymes involved and the biological roles that have been assigned to plasmalogens.

[1]  R. Wanders,et al.  Chondrodysplasia punctata with a mild clinical course , 1994, Journal of Inherited Metabolic Disease.

[2]  R. Wanders,et al.  Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. , 1993, Clinical chemistry.

[3]  P. Devaux,et al.  Transmembrane distribution and translocation of spin-labeled plasmalogens in human red blood cells. , 1993, Chemistry and physics of lipids.

[4]  P. Vreken,et al.  Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells. , 1998, Biochemical and biophysical research communications.

[5]  H. Moser,et al.  Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis , 1998 .

[6]  Burton J. Litman,et al.  Optimization of Receptor-G Protein Coupling by Bilayer Lipid Composition I , 2001, The Journal of Biological Chemistry.

[7]  H. van den Bosch,et al.  Topography of ether phospholipid biosynthesis. , 1989, Biochimica et biophysica acta.

[8]  H. Moser,et al.  Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. , 1999, Journal of lipid research.

[9]  T. Lee,et al.  Biosynthesis and possible biological functions of plasmalogens. , 1998, Biochimica et biophysica acta.

[10]  R. Catalán,et al.  Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide. , 2003, European journal of biochemistry.

[11]  L. Horrocks,et al.  Lysoplasmalogenase: solubilization and partial purification from liver microsomes. , 1991, Methods in enzymology.

[12]  H. Waterham,et al.  Identification of PEX7 as the second gene involved in Refsum disease. , 2003, American journal of human genetics.

[13]  N. Rotstein,et al.  Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. , 2003, Investigative ophthalmology & visual science.

[14]  H. Moser,et al.  Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion. , 1998, Biochemical and biophysical research communications.

[15]  H. Tabak,et al.  Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. , 2002, American journal of human genetics.

[16]  L. Horrocks,et al.  Plasmalogens, phospholipases A2 and signal transduction , 1995, Brain Research Reviews.

[17]  K. Beckman,et al.  Exclusive localization in peroxisomes of dihydroxyacetone phosphate acyltransferase and alkyl-dihydroxyacetone phosphate synthase in rat liver. , 1993, Journal of lipid research.

[18]  D. Valle,et al.  Peroxisome biogenesis disorders. , 2003, Annual review of genomics and human genetics.

[19]  R. Brady,et al.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Gutteridge,et al.  Lipid peroxidation and antioxidants as biomarkers of tissue damage. , 1995, Clinical chemistry.

[21]  K. Wisniewski,et al.  New subform of the late infantile form of neuronal ceroid lipofuscinosis. , 1993, Neuropediatrics.

[22]  B. Rosner,et al.  Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. , 1992, Investigative ophthalmology & visual science.

[23]  Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns , 2002 .

[24]  M. Ghosh,et al.  Subcellular distribution and properties of acyl/alkyl dihydroxyacetone phosphate reductase in rodent livers. , 1986, Archives of biochemistry and biophysics.

[25]  H. Moser,et al.  Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells , 1999, Acta Neuropathologica.

[26]  S Subramani,et al.  Import of peroxisomal matrix and membrane proteins. , 2000, Annual review of biochemistry.

[27]  M. Ghosh,et al.  Purification and properties of acyl/alkyl dihydroxyacetone-phosphate reductase from guinea pig liver peroxisomes. , 1990, The Journal of biological chemistry.

[28]  R. Wanders,et al.  Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata — a complementation study , 1992, Human Genetics.

[29]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[30]  H. Hayashi,et al.  Fatty alcohol synthesis accompanied with chain elongation in liver peroxisomes. , 1997, Biochimica et biophysica acta.

[31]  R. Mcinnes,et al.  Progress toward understanding the genetic and biochemical mechanisms of inherited photoreceptor degenerations. , 2003, Annual review of neuroscience.

[32]  H. Goebel,et al.  The Neuronal Ceroid‐Lipofuscinoses. Recent Advances , 1998, Brain pathology.

[33]  A. Hajra Dihydroxyacetone phosphate acyltransferase. , 1997, Biochimica et biophysica acta.

[34]  P. Carmeliet,et al.  A mouse model for Zellweger syndrome , 1997, Nature Genetics.

[35]  S. Rapoport,et al.  Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain , 1995, Brain Research.

[36]  H. van den Bosch,et al.  The native molecular size of alkyl-dihydroxyacetonephosphate synthase and dihydroxyacetonephosphate acyltransferase. , 1998, Biochimica et biophysica acta.

[37]  L. Horrocks,et al.  Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia , 2001 .

[38]  H. Waterham,et al.  Identification of human PMP34 as a peroxisomal ATP transporter. , 2002, Biochemical and biophysical research communications.

[39]  R. Wanders,et al.  The cerebro-hepato-renal (Zellweger) syndrome. Impaired de novo biosynthesis of plasmalogens in cultured skin fibroblasts. , 1985, Biochimica et biophysica acta.

[40]  D. Johnson,et al.  Rhizomelic chondrodysplasia punctata: clinical, pathologic, and biochemical findings in two patients. , 1988, The Journal of pediatrics.

[41]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[42]  J. Xuereb,et al.  Membrane Instability, Plasmalogen Content, and Alzheimer's Disease , 1998, Journal of neurochemistry.

[43]  C. Rock,et al.  A short-chain acyl-CoA: 1-alkyl-2-acyl-sn-glycerol acyltrasnferase from a microsomal fraction of the rabbit Harderian gland. , 1975, Biochimica et biophysica acta.

[44]  D. Kirschner,et al.  Myelin labeled with mercuric chloride. Asymmetric localization of phosphatidylethanolamine plasmalogen. , 1982, Journal of molecular biology.

[45]  D. Ford,et al.  Activation of myocardial cAMP‐dependent protein kinase by lysoplasmenylcholine , 1997, FEBS letters.

[46]  A. Das,et al.  Induction of the Peroxisomal Glycerolipid-synthesizing Enzymes during Differentiation of 3T3-L1 Adipocytes , 2000, The Journal of Biological Chemistry.

[47]  D. Portilla,et al.  cDNA cloning and expression of a novel family of enzymes with calcium-independent phospholipase A2 and lysophospholipase activities. , 1998, Journal of the American Society of Nephrology : JASN.

[48]  R. Zoeller,et al.  Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200363-JLR200 , 2003, Journal of Lipid Research.

[49]  J. Infante Biosynthesis of acyl‐specific glycerophospholipids in mammalian tissues , 1984, FEBS letters.

[50]  R. Wanders,et al.  Alkyl-Dihydroxyacetonephosphate Synthase , 1998, The Journal of Biological Chemistry.

[51]  C. Hübner,et al.  Low erythrocyte plasmalogen and plasma docosahexaenoic acid (DHA) in juvenile neuronal ceroid-lipofuscinosis (JNCL) , 1993, Journal of Inherited Metabolic Disease.

[52]  P. K. Chakraborty,et al.  Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype , 2002, Human mutation.

[53]  B. Engelmann,et al.  Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. , 1997, The Biochemical journal.

[54]  G. Durand,et al.  Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus , 2000, Neurobiology of Aging.

[55]  M. Haltia The Neuronal Ceroid–Lipofuscinoses , 2003, Journal of neuropathology and experimental neurology.

[56]  F. Paltauf,et al.  Ether lipids in biomembranes. , 1994, Chemistry and physics of lipids.

[57]  J. Gunawan,et al.  Lysoplasmalogenase–A Microsomal Enzyme from Rat Brain , 1982, Journal of neurochemistry.

[58]  Xianlin Han,et al.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.

[59]  U. Honegger,et al.  Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol. , 2002, Biochimica et biophysica acta.

[60]  C. Leray,et al.  Phospholipid composition in late infantile neuronal ceroid lipofuscinosis , 2000, European journal of clinical investigation.

[61]  D. C. Mitchell,et al.  DHA-rich phospholipids optimize G-Protein-coupled signaling. , 2003, The Journal of pediatrics.

[62]  A. Hermetter,et al.  Influence of plasmalogen deficiency on membrane fluidity of human skin fibroblasts: a fluorescence anisotropy study. , 1989, Biochimica et biophysica acta.

[63]  R. Wanders,et al.  Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT‐deficiency) , 2000, Developmental medicine and child neurology.

[64]  D. Portilla,et al.  Hypoxia-induced amphiphiles inhibit renal Na+, K(+)-ATPase. , 1996, Kidney international.

[65]  G. Dallner,et al.  Peroxisomal Impairment in Niemann-Pick Type C Disease* , 1997, The Journal of Biological Chemistry.

[66]  R. Gross,et al.  Rat and human pancreatic islet cells contain a calcium ion independent phospholipase A2 activity selective for hydrolysis of arachidonate which is stimulated by adenosine triphosphate and is specifically localized to islet beta-cells. , 1993, Biochemistry.

[67]  T. Mock,et al.  The catabolism of plasmenylcholine in the guinea pig heart. , 1986, The Biochemical journal.

[68]  D. Portilla,et al.  Purification of a Novel Calcium-independent Phospholipase A2 from Rabbit Kidney* , 1996, The Journal of Biological Chemistry.

[69]  N. Nagan,et al.  Plasmalogens: biosynthesis and functions. , 2001, Progress in lipid research.

[70]  Klaus-Armin Nave,et al.  Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. , 2003, Human molecular genetics.

[71]  B. Roelofsen,et al.  Plasmalogen content and distribution in the sarcolemma of cultured neonatal rat myocytes , 1988, FEBS letters.

[72]  M. Hims,et al.  Retinitis pigmentosa: genes, proteins and prospects. , 2003, Developments in ophthalmology.

[73]  P. Carmeliet,et al.  Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata. , 2003, Human molecular genetics.

[74]  D. Birch,et al.  Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. , 2001, Journal of lipid research.

[75]  P. Fleming,et al.  1-Alkyl-sn-glycero-3-phosphate: acyl-CoA acyltransferase in rat brain microsomes. , 1977, The Journal of biological chemistry.

[76]  D. Valle,et al.  Peroxisome biogenesis disorders: genetics and cell biology. , 2000, Trends in genetics : TIG.

[77]  V. Di Marzo Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[78]  A. Moser,et al.  Biochemical abnormalities in rhizomelic chondrodysplasia punctata. , 1988, The Journal of pediatrics.

[79]  A. Alkan,et al.  Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings. , 2003, Magnetic resonance imaging.

[80]  J. Opitz,et al.  Heterogeneity of Chondrodysplasia punctata , 2004, Humangenetik.

[81]  L. Horrocks,et al.  Solubilization, purification and characterization of lysoplasmalogen alkenylhydrolase (lysoplasmalogenase) from rat liver microsomes. , 1989, Biochimica et biophysica acta.

[82]  V. Marzo Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. , 1995 .

[83]  B. Engelmann,et al.  Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[84]  E. Gottfried,et al.  Hereditary nonspherocytic hemolytic disease associated with an altered phospholipid composition of the erythrocytes. , 1968, The Journal of clinical investigation.

[85]  S. Hazen,et al.  Purification and characterization of canine myocardial cytosolic phospholipase A2. A calcium-independent phospholipase with absolute f1-2 regiospecificity for diradyl glycerophospholipids. , 1990, The Journal of biological chemistry.

[86]  F. Snyder,et al.  Ether-Linked Glycerolipids and Their Bioactive Species:Enzymes and Metabolic Regulation , 1985 .

[87]  H. Waterham,et al.  Biochemical markers predicting survival in peroxisome biogenesis disorders , 2002, Neurology.

[88]  H. Goebel The neuronal ceroid-lipofuscinoses. , 1995, Journal of child neurology.

[89]  B. Landing,et al.  Studies of vertebral coronal cleft in rhizomelic chondrodysplasia punctata. , 1992, Pediatric pathology.

[90]  R. Wanders,et al.  Etherphospholipid biosynthesis and dihydroxyactetone-phosphate acyltransferase: resolution of the genomic organization of the human gnpat gene and its use in the identification of novel mutations. , 2001, Biochemical and biophysical research communications.

[91]  Anthony N. Martonosi,et al.  The Enzymes of Biological Membranes , 1985, Springer US.

[92]  M. Rüdiger,et al.  Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures. , 1998, The American journal of physiology.

[93]  K. Hofmann,et al.  Effect of cholesterol and surfactant protein B on the viscosity of phospholipid mixtures. , 2002, Chemistry and physics of lipids.

[94]  G. Kay,et al.  Pex13 Inactivation in the Mouse Disrupts Peroxisome Biogenesis and Leads to a Zellweger Syndrome Phenotype , 2003, Molecular and Cellular Biology.

[95]  G. Spiteller,et al.  Lipid oxidation products in ischemic porcine heart tissue. , 1996, Chemistry and physics of lipids.

[96]  K. Lohner,et al.  Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? , 1996, Chemistry and physics of lipids.

[97]  I. Singh,et al.  Intraperoxisomal localization of very-long-chain fatty acyl-CoA synthetase: implication in X-adrenoleukodystrophy. , 2000, Experimental cell research.

[98]  R. G. Holmes,et al.  Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy. , 1986, American journal of medical genetics.

[99]  R. Wanders,et al.  Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. , 1998, Human molecular genetics.

[100]  H. Moser,et al.  Genetic and Phenotypic Heterogeneity in Disorders of Peroxisome Biogenesis—A Complementation Study Involving Cell Lines from 19 Patients , 1989, Pediatric Research.

[101]  E. D. de Vet,et al.  Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2. , 1997, Biochimica et biophysica acta.

[102]  L. Horrocks,et al.  Plasmalogen-selective phospholipase A2 and its role in signal transduction. , 1996, Journal of lipid mediators and cell signalling.

[103]  F. Opperdoes,et al.  Cloning and characterization of the NAD-linked glycerol-3-phosphate dehydrogenases of Trypanosoma brucei brucei and Leishmania mexicana mexicana and expression of the trypanosome enzyme in Escherichia coli. , 1996, Molecular and biochemical parasitology.

[104]  R. Zoeller,et al.  Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants. , 1999, Journal of lipid research.

[105]  L. Binaglia,et al.  Purification of ethanolaminephosphotransferase from bovine liver microsomes. , 1999, Biochimica et biophysica acta.

[106]  A. Hajra,et al.  GLYCEROLIPID BIOSYNTHESIS IN PEROXISOMES VIA THE ACYL DIHYDROXYACETONE PHOSPHATE PATHWAY * , 1982, Annals of the New York Academy of Sciences.

[107]  M. Bennett,et al.  Juvenile neuronal ceroid-lipofuscinosis: Characterization of the dyslipoproteinaemia and demonstration of membrane phospholipid and phospholipid-dependent signal transduction abnormalities in cultured skin fibroblasts , 1993, Journal of Inherited Metabolic Disease.

[108]  F. Snyder,et al.  Alkyldihydroxyacetone-P synthase. Solubilization, partial purification, new assay method, and evidence for a ping-pong mechanism. , 1982, The Journal of biological chemistry.

[109]  A. Moser,et al.  Impaired membrane traffic in defective ether lipid biosynthesis. , 2001, Human molecular genetics.

[110]  P. Watkins,et al.  Human liver-specific very-long-chain acyl-coenzyme A synthetase: cDNA cloning and characterization of a second enzymatically active protein. , 1999, Molecular genetics and metabolism.

[111]  B. Rosner,et al.  Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. , 1995, Journal of lipid research.

[112]  W. Lieberthal,et al.  Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. , 1999, The Biochemical journal.

[113]  A. Hermetter,et al.  Stabilization of non-bilayer structures by the etherlipid ethanolamine plasmalogen. , 1991, Biochimica et biophysica acta.

[114]  P. Stevens,et al.  Synthesis and secretion of plasmalogens by type-II pneumocytes. , 1994, The Biochemical journal.

[115]  M. Hatten,et al.  Targeted Deletion of the PEX2 Peroxisome Assembly Gene in Mice Provides a Model for Zellweger Syndrome, a Human Neuronal Migration Disorder , 1997, The Journal of cell biology.

[116]  K. Webber,et al.  Dihydroxyacetone phosphate acyltransferase. , 1992, Methods in enzymology.

[117]  R. Wanders,et al.  Alkyl-dihydroxyacetone phosphate synthase and dihydroxyacetone phosphate acyltransferase form a protein complex in peroxisomes. , 1999, European journal of biochemistry.

[118]  Xianlin Han,et al.  Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. , 2002, Biochemistry.

[119]  K. Wisniewski,et al.  Abnormal processing of carboxy-terminal fragment of beta precursor protein (βPP) in neuronal ceroid-lipofuscinosis (NCL) cases , 1993, Journal of Inherited Metabolic Disease.

[120]  P. Henkind,et al.  Pathology of retinitis pigmentosa. , 1982, Ophthalmology.

[121]  S. Hazen,et al.  The rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia. , 1991, The Journal of clinical investigation.

[122]  H. Bosch,et al.  Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2 , 1997 .

[123]  R. Dluhy,et al.  Identification of phosphocholine plasmalogen as a lipid component in mammalian pulmonary surfactant using high-resolution 31P NMR spectroscopy. , 1993, Biochemistry.

[124]  F. Snyder,et al.  Effects of eicosapentaenoic and docosahexaenoic acid supplements on phospholipid composition and plasmalogen biosynthesis in P388D1 cells. , 1989, Archives of biochemistry and biophysics.

[125]  F. Snyder,et al.  Biosynthesis of choline plasmalogens in neonatal rat myocytes. , 1991, Archives of biochemistry and biophysics.

[126]  R. Brady,et al.  Niemann-Pick type-C disease: deficient intracellular transport of exogenously derived cholesterol. , 1992, American journal of medical genetics.

[127]  R. Gross,et al.  Alterations in membrane dynamics elicited by amphiphilic compounds are augmented in plasmenylcholine bilayers. , 1991, Biochimica et biophysica acta.

[128]  R. Gross,et al.  Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion. , 1994, Biochemistry.

[129]  E. Wiemer,et al.  Kinetics of the assembly of peroxisomes after fusion of complementary cell lines from patients with the cerebro-hepato-renal (Zellweger) syndrome and related disorders. , 1988, Biochemical and biophysical research communications.

[130]  M. Creer,et al.  Selective hydrolysis of plasmalogen phospholipids by Ca 2 1-independent PLA 2 in hypoxic ventricular myocytes , 1998 .

[131]  J. Ranjeva,et al.  MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata. , 2002, AJNR. American journal of neuroradiology.

[132]  L. Horrocks,et al.  Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[133]  N. Weber,et al.  Biosynthesis and biotransformation of ether lipids , 1987, Lipids.

[134]  R. Zoeller,et al.  Increasing plasmalogen levels protects human endothelial cells during hypoxia. , 2002, American journal of physiology. Heart and circulatory physiology.

[135]  Carlo Rivolta,et al.  Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. , 2002, Human molecular genetics.

[136]  S. Rapoport,et al.  Phospholipid composition and levels are altered in down syndrome brain , 2000, Brain Research.

[137]  L. Horrocks,et al.  Characterization of plasmalogen-selective phospholipase A2 from bovine brain. , 1996, Advances in experimental medicine and biology.

[138]  D. Ford,et al.  Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[139]  G. Dallner,et al.  The protective role of plasmalogens in iron-induced lipid peroxidation. , 1999, Free radical biology & medicine.

[140]  S. Rapoport,et al.  85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. , 1999, Neuroreport.